OHRP—I missed this PR from mid-2014: http://ir.ohrpharmaceutical.com/press-releases/detail/194/depymed-announces-validation-of-trodusquemine-as-a-therapeutic-candidate-for-her2-positive-breast-cancer Hard to believe that Cold Spring Laboratory is interested in Trodusquemine, the former “obesity” drug from Genaera, as a cancer treatment.